PortfoliosLab logo
HROW vs. CAVA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HROW and CAVA is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

HROW vs. CAVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Harrow Health, Inc. (HROW) and CAVA Group Inc. (CAVA). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

HROW:

1.56

CAVA:

0.43

Sortino Ratio

HROW:

2.76

CAVA:

1.01

Omega Ratio

HROW:

1.33

CAVA:

1.14

Calmar Ratio

HROW:

1.33

CAVA:

0.52

Martin Ratio

HROW:

3.70

CAVA:

1.21

Ulcer Index

HROW:

33.22%

CAVA:

21.82%

Daily Std Dev

HROW:

88.78%

CAVA:

57.92%

Max Drawdown

HROW:

-99.46%

CAVA:

-50.91%

Current Drawdown

HROW:

-82.32%

CAVA:

-37.76%

Fundamentals

Market Cap

HROW:

$895.12M

CAVA:

$10.86B

EPS

HROW:

-$0.49

CAVA:

$1.10

PS Ratio

HROW:

4.48

CAVA:

11.27

PB Ratio

HROW:

12.42

CAVA:

15.62

Total Revenue (TTM)

HROW:

$212.86M

CAVA:

$704.71M

Gross Profit (TTM)

HROW:

$158.64M

CAVA:

$236.25M

EBITDA (TTM)

HROW:

$24.97M

CAVA:

$89.46M

Returns By Period

In the year-to-date period, HROW achieves a -27.27% return, which is significantly lower than CAVA's -16.75% return.


HROW

YTD

-27.27%

1M

3.92%

6M

-53.53%

1Y

110.34%

5Y*

41.21%

10Y*

11.89%

CAVA

YTD

-16.75%

1M

5.79%

6M

-36.20%

1Y

18.77%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HROW vs. CAVA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HROW
The Risk-Adjusted Performance Rank of HROW is 8989
Overall Rank
The Sharpe Ratio Rank of HROW is 9292
Sharpe Ratio Rank
The Sortino Ratio Rank of HROW is 9393
Sortino Ratio Rank
The Omega Ratio Rank of HROW is 9090
Omega Ratio Rank
The Calmar Ratio Rank of HROW is 8888
Calmar Ratio Rank
The Martin Ratio Rank of HROW is 8282
Martin Ratio Rank

CAVA
The Risk-Adjusted Performance Rank of CAVA is 6868
Overall Rank
The Sharpe Ratio Rank of CAVA is 6969
Sharpe Ratio Rank
The Sortino Ratio Rank of CAVA is 6666
Sortino Ratio Rank
The Omega Ratio Rank of CAVA is 6666
Omega Ratio Rank
The Calmar Ratio Rank of CAVA is 7474
Calmar Ratio Rank
The Martin Ratio Rank of CAVA is 6767
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HROW vs. CAVA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Harrow Health, Inc. (HROW) and CAVA Group Inc. (CAVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current HROW Sharpe Ratio is 1.56, which is higher than the CAVA Sharpe Ratio of 0.43. The chart below compares the historical Sharpe Ratios of HROW and CAVA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

HROW vs. CAVA - Dividend Comparison

Neither HROW nor CAVA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

HROW vs. CAVA - Drawdown Comparison

The maximum HROW drawdown since its inception was -99.46%, which is greater than CAVA's maximum drawdown of -50.91%. Use the drawdown chart below to compare losses from any high point for HROW and CAVA. For additional features, visit the drawdowns tool.


Loading data...

Volatility

HROW vs. CAVA - Volatility Comparison

Harrow Health, Inc. (HROW) has a higher volatility of 14.48% compared to CAVA Group Inc. (CAVA) at 13.54%. This indicates that HROW's price experiences larger fluctuations and is considered to be riskier than CAVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

HROW vs. CAVA - Financials Comparison

This section allows you to compare key financial metrics between Harrow Health, Inc. and CAVA Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M20212022202320242025
47.83M
227.40M
(HROW) Total Revenue
(CAVA) Total Revenue
Values in USD except per share items

HROW vs. CAVA - Profitability Comparison

The chart below illustrates the profitability comparison between Harrow Health, Inc. and CAVA Group Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20212022202320242025
67.5%
22.6%
(HROW) Gross Margin
(CAVA) Gross Margin
HROW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Harrow Health, Inc. reported a gross profit of 32.31M and revenue of 47.83M. Therefore, the gross margin over that period was 67.5%.

CAVA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, CAVA Group Inc. reported a gross profit of 51.43M and revenue of 227.40M. Therefore, the gross margin over that period was 22.6%.

HROW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Harrow Health, Inc. reported an operating income of -11.23M and revenue of 47.83M, resulting in an operating margin of -23.5%.

CAVA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, CAVA Group Inc. reported an operating income of 3.95M and revenue of 227.40M, resulting in an operating margin of 1.7%.

HROW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Harrow Health, Inc. reported a net income of -17.78M and revenue of 47.83M, resulting in a net margin of -37.2%.

CAVA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, CAVA Group Inc. reported a net income of 78.62M and revenue of 227.40M, resulting in a net margin of 34.6%.